ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

New Study Shows Effective New Approach to Collagen Supplementation

-- A precise vegan amino acid blend was shown to be effective in improving skin hydration and texture more effectively than whole collagen molecules. The new study, published in Nature’s npj aging and led by Prof. Collin Ewald at ETH Zurich, shows the results of a four-year translational journey, from mice to human clinical trials, identifying that a precise 3:1:1 ratio of the amino acids Glycine, Proline, and Hydroxyproline increases collagen synthesis in the most effective way.

The Swiss supplement brand AVEA worked with the researchers to develop a consumer- ready product to bring this new approach to the market. The AVEA Collagen Activator contains the exact ingredients used in the study and is now available globally. It has immediately become a successful product in various markets such as Switzerland, Germany, Italy and China.

AVEA Researchers in the lab

The results of the final human trial (N=66) at Hautwerk Clinic in Zurich were significant. Study participants were analysed with a VISIA skin scanner and a Corneometer monthly. Within 3 months study participants improved their skin quality:

  • Skin hydration improved by an impressive 34% on average
  • Skin texture improved by 8.5% leading to significant improvement in skin elasticity

As collagen is a large consumer market with lots of conflicting claims, the peer-reviewed study is a great addition to the research pool in the field and a serious argument that there are indeed ways to improve the skin through supplementation.

This is one of the few instances where a supplement compound has been successfully translated from basic research to a consumer-ready product with validated human clinical data in a short timeframe.

AVEA is a Swiss company focused on the development of science-backed dietary supplements that target key hallmarks of aging, including energy and NAD+ metabolism, collagen production and skin health, joint mobility, gut health, blood sugar balance and sleep. The company invests in clinical research, university collaborations and third-party testing, translating cutting-edge longevity science into accessible, easy-to-understand products. Besides the study on collagen currently various studies on supplements for sleep and daily energy are in the works.

The full study can be found here: https://www.nature.com/articles/s41514-025-00280-7

Contact Info:
Name: Duri Granziol
Email: Send Email
Organization: AVEA
Website: https://www.avea-life.com

Release ID: 89183776

Should you detect any errors, issues, or discrepancies with the content contained within this press release, or if you need assistance with a press release takedown, we kindly request that you inform us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our expert team will be available to promptly respond and take necessary steps within the next 8 hours to resolve any identified issues or guide you through the removal process. We value the trust placed in us by our readers and remain dedicated to providing accurate and reliable information.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.11
+5.25 (2.56%)
AAPL  264.58
+4.00 (1.54%)
AMD  200.15
-3.22 (-1.58%)
BAC  53.06
+0.29 (0.55%)
GOOG  314.90
+11.34 (3.74%)
META  655.66
+10.88 (1.69%)
MSFT  397.23
-1.23 (-0.31%)
NVDA  189.82
+1.92 (1.02%)
ORCL  148.08
-8.46 (-5.40%)
TSLA  411.82
+0.11 (0.03%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.